Balawag, Remwel G.

HRN: 22-41-38  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/25/2023
CEFUROXIME 1.5GM (VIAL)
12/25/2023
01/01/2024
IVTT
300mg
Q8
PCAP C
Waiting Final Action 
12/27/2023
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
12/27/2023
01/03/2024
ORAL
3ml
Bid
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: